ClinicalTrials.govpublic full text
EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study
neuropsychiatric systemic lupus erythematosus, systemic lupus erythematosus (sle), cognitive impairment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839041
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.